The F.D.A. ended its recommended pause on the J.&J. vaccine,

The F.D.A. ended its recommended pause on the J.&J. vaccine, clearing the way for states to use it again.
A vial containing doses of the Johnson & Johnson Covid-19 vaccine.Credit...Bryan Anselm for The New York Times
April 23, 2021, 5:02 a.m. ET
The Food and Drug Administration ended its recommended pause on the Johnson & Johnson Covid-19 vaccine on Friday and will add a warning to its label to note the potential risk of rare blood clots.
The decision, which clears the way for states to resume vaccinations, came after a panel of advisers to the Centers for Disease Control and Prevention voted to end the pause in a meeting on Friday.

Related Keywords

United States , Joanne Waldstreicher , Johnson Covid , Centers For Disease , European Union , Drug Administration , Johnson , Disease Control , Internal Tag To Designate Essential Content , Blood Clot , Vaccines Immunization , Coronavirus Covid 19 , Product Labels , Advisory Committee On Immunization Practices , Cdc , ஒன்றுபட்டது மாநிலங்களில் , மையங்கள் க்கு நோய் , ஐரோப்பிய தொழிற்சங்கம் , ஜான்சன் , நோய் கட்டுப்பாடு , இரத்தம் உறைதல் , தடுப்பு மருந்துகள் நோய்த்தடுப்பு , ப்ராடக்ட் லேபிள்கள் , ஸீடீக் ,